Debt Financing - Alladapt Immunotherapeutics
Investment Firm
Overview
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Announced Date
Aug 30, 2022
Funding Type
Debt Financing
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Alladapt Immunotherapeutics raised $50000000 on 2022-08-30 in Debt Financing
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 20, 2020 |  Series C - Alladapt Immunotherapeutics | 9 | - | 60.0M |
| Jun 22, 2022 | Venture Round - Alladapt Immunotherapeutics | 6 | - | 119.0M |
| Aug 30, 2022 | Debt Financing - Alladapt Immunotherapeutics | 1 | - | 50.0M |
Recent Activity
There is no recent news or activity for this profile.